Wipfli Financial Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Wipfli Financial Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$0	Buy	+1	New	+$17	﹤0.01%	2559

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Quantedge Capital Singapore $183M AUM 37.27% 1-Year Est. Return

COLIM

City of London Investment Management London, United Kingdom $1.38B AUM 42.43% 1-Year Est. Return

Wipfli Financial Advisors's BMEZ Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in BlackRock Health Sciences Trust II (BMEZ) in Q3 2022: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #2559 among its holdings.

75 funds tracked by Wall St. Rank hold BMEZ as of Q3 2022.

Wipfli Financial Advisors held 1 share of BlackRock Health Sciences Trust II worth $0 as of Q3 2022.
BlackRock Health Sciences Trust II was a new Wipfli Financial Advisors position in Q3 2022.
BlackRock Health Sciences Trust II made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2559 holding.
75 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.